Health ❯Healthcare ❯Regulatory Agencies

European Medicines Agency

Market Authorization Drug Recommendations Food and Drug Administration Drug Approval Process Drug Regulation Drug Market Authorization Drug Safety

EMA Rejects Eli Lilly's Alzheimer's Drug Kisunla Over Safety Concerns

EU Drug Agency Recommends Approval of First Alzheimer’s Treatment Targeting Disease Progression

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

New Studies Confirm Safety of Semaglutide for Mental Health

EU Regulator Denies Approval for Alzheimer's Drug Lecanemab